This is a $80,568 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Life Technologies Corporation, a division of Thermo Fisher Scientific, to conduct testing of compounds against a panel of kinase assays. The contract was awarded in response to a full and open competition under simplified acquisition procedures, with no set-aside designation. The work supports the translational research initiatives of the National Center for...
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...
This is a $1,126,465.00 Firm Fixed Price contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for IPSC Engineering Services with a period of performance through September 29, 2024. No set-aside was used. Life Technologies, a division of Thermo Fisher Scientific, has a history of providing genetic analysis technologies, instrumentation,...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
This $34,884 fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Reaction Biology Corporation, a small disadvantaged business, to conduct kinase inhibition testing on 100 novel small molecule compounds. The contract supports the work of the National Center for Advancing Translational Sciences (NCATS) within NIH, which is focused on developing potential anti-cancer agents. Reaction Biology will use its...
The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $240,532.97 firm-fixed-price purchase order to Thermo Electron North America LLC, doing business as Thermofisher Scientific, to provide maintenance services for a Thermo Fisher Orbitrap Fusion Lumos ETD LC-MS system used by NIDA's Protein/Peptide Sequencing Facility. The contract has a period of performance from April 30, 2019 through April 29, 2023 and does not utilize...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,124,632.49 firm-fixed price contract to Thermo Electron North America LLC, doing business as Thermofisher Scientific, for a Fusion Lumos ETD mass spectrometer and related accessories. This award was made on an open, full and competitive basis and did not utilize any set-aside designations. The contract is to support the National Center for Advancing Translational Sciences...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract worth $265,048.50 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of assorted cell culture medium, substrate, and supplements manufactured by Life Technologies. This contract supports the Stem Cell Translation Laboratory within the National...
This is a non-competitive firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), to Life Technologies Corporation (doing business as Thermo Fisher Scientific) for a Preventative Maintenance and Service Agreement for a Quantstudio 12K instrument. The purchase order has a 1-year base period with two 1-year option periods, for a total potential value of $49,454.40. The contract provides...